← Back to Analyst Consensus 
CCCC Buy
C4 Therapeutics, Inc.
Current Price —
Implied Upside —
Analysts 13
30-Day Momentum
▲ 1 upgrades / ▼ 0 downgrades / 0 reiterations from 1 firms
Next Earnings
Nov 4, 2026 (9 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 9, 2026 | JP Morgan | initiate | — → Overweight | — | 54% |
| Jun 1, 2026 | Evercore ISI Group | maintain | Outperform → Outperform | — | 58% |
| Feb 27, 2026 | Barclays | maintain | Overweight → Overweight | $7 | 53% |
| Feb 23, 2026 | Brookline Capital | maintain | Buy → Buy | $30 | 38% |
| Dec 17, 2025 | Barclays | maintain | Overweight → Overweight | $5 | 53% |
| Dec 2, 2025 | TD Cowen | initiate | — → Buy | $0 | 54% |
| Sep 23, 2025 | Wells Fargo | maintain | Overweight → Overweight | $10 | 54% |
| Sep 23, 2025 | Barclays | maintain | Overweight → Overweight | $10 | 53% |
| Sep 22, 2025 | Stephens & Co. | reiterate | Overweight → Overweight | $6 | 54% |
| Sep 17, 2025 | Barclays | initiate | — → Overweight | $8 | 53% |
| Sep 15, 2025 | Stephens & Co. | upgrade | Equal-Weight → Overweight | $6 | 54% |
| Sep 4, 2025 | Guggenheim | initiate | — → Buy | $8 | 52% |
| Dec 19, 2024 | Wells Fargo | upgrade | Equal-Weight → Overweight | $12 | 54% |
| Nov 18, 2024 | Stephens & Co. | initiate | — → Equal-Weight | $4 | 54% |
| Aug 6, 2024 | BMO Capital | reiterate | Outperform → Outperform | $20 | 53% |
| May 9, 2024 | Wells Fargo | maintain | Equal-Weight → Equal-Weight | $8 | 54% |
| May 9, 2024 | Stifel | maintain | Buy → Buy | $14 | 53% |
| Feb 26, 2024 | Morgan Stanley | maintain | Equal-Weight → Equal-Weight | $8 | 54% |
| Feb 23, 2024 | Stifel | reiterate | Buy → Buy | $13 | 53% |
| Jan 29, 2024 | JP Morgan | upgrade | Underweight → Neutral | $6 | 54% |
| Dec 13, 2023 | Stifel | upgrade | Hold → Buy | $12 | 53% |
| Nov 6, 2023 | Morgan Stanley | upgrade | Underweight → Equal-Weight | $1 | 54% |
| Nov 3, 2023 | BMO Capital | maintain | Outperform → Outperform | $16 | 53% |
| Nov 2, 2023 | HC Wainwright & Co. | maintain | Buy → Buy | $7 | 44% |
| Oct 9, 2023 | B of A Securities | maintain | Neutral → Neutral | $2 | 53% |
| Aug 9, 2023 | HC Wainwright & Co. | maintain | Buy → Buy | $17 | 44% |
| May 30, 2023 | Evercore ISI Group | maintain | — → Outperform | $10 | 58% |
| May 12, 2023 | Morgan Stanley | maintain | Underweight → Underweight | $3 | 54% |
| May 8, 2023 | HC Wainwright & Co. | maintain | — → Buy | $25 | 44% |
| Mar 28, 2023 | B of A Securities | maintain | — → Neutral | $5 | 53% |
| Feb 27, 2023 | Morgan Stanley | maintain | — → Underweight | $5 | 54% |
| Feb 24, 2023 | HC Wainwright & Co. | reiterate | — → Buy | $35 | 44% |
| Feb 24, 2023 | JP Morgan | downgrade | Neutral → Underweight | $5 | 54% |
| Jan 3, 2023 | Wells Fargo | maintain | — → Equal-Weight | $9 | 54% |
| Nov 8, 2022 | Wells Fargo | maintain | — → Equal-Weight | $11 | 54% |
| Nov 4, 2022 | JP Morgan | downgrade | Overweight → Neutral | $15 | 54% |
| Oct 11, 2022 | Morgan Stanley | initiate | — → Underweight | $6 | 54% |
| May 9, 2022 | HC Wainwright & Co. | maintain | — → Buy | $35 | 44% |
| Apr 28, 2022 | Credit Suisse | initiate | — → Underperform | $10 | — |
| Apr 18, 2022 | UBS | maintain | — → Buy | $26 | 54% |
| Apr 11, 2022 | BMO Capital | maintain | — → Outperform | $20 | 53% |
| Mar 10, 2022 | JP Morgan | initiate | — → Overweight | $43 | 54% |
| Feb 10, 2022 | Wells Fargo | initiate | — → Equal-Weight | $25 | 54% |
| Nov 23, 2021 | B of A Securities | initiate | — → Buy | $54 | 53% |
| Oct 14, 2021 | SVB Leerink | initiate | — → Outperform | $67 | — |
| Sep 30, 2021 | Stifel | initiate | — → Hold | $45 | 53% |
| Jun 24, 2021 | Brookline Capital | initiate | — → Buy | $54 | 38% |
| Jun 4, 2021 | HC Wainwright & Co. | initiate | — → Buy | $63 | 44% |
| Mar 31, 2021 | BMO Capital | initiate | — → Outperform | $55 | 53% |
| Oct 27, 2020 | BMO Capital | initiate | — → Outperform | $33 | 53% |
Price Target Trend
May 12, 2026 Oct 26, 2026
EPS Estimates
0y —
+1q —
0q —
+1y —
Cross-Platform Signals
No cross-platform signals in the last 90 days